Contrast-induced nephropathy in interventional cardiology

Area of Science:

• Nephrology
• Cardiology
• Radiology

Background:

• Contrast-induced nephropathy (CIN) is a significant complication after cardiac procedures, increasing morbidity and mortality.
• CIN prevalence varies widely, influenced by patient risk factors like chronic kidney disease and diabetes.
• Understanding CIN pathophysiology is crucial for developing effective preventive strategies.

Purpose of the Study:

• To review current understanding and prevention strategies for contrast-induced nephropathy (CIN).
• To identify established and potential risk factors for CIN development.
• To evaluate the efficacy of various interventions for CIN prevention.

Main Methods:

• Literature review of studies on contrast-induced nephropathy.
• Analysis of risk factors associated with CIN.
• Evaluation of preventive strategies, including hydration and pharmacological agents.

Main Results:

• Hydration to ensure brisk diuresis is the primary effective preventive measure for CIN.
• Key risk factors for CIN include chronic renal insufficiency, diabetes, advanced age, and contrast volume.
• N-acetylcysteine shows mixed efficacy but is often recommended due to low cost and safety.
• Several agents like dopamine and statins have shown no benefit or potential harm in preventing CIN.

Conclusions:

• Optimizing long-term outcomes after percutaneous coronary intervention necessitates effective CIN prevention.
• Controlled hydration and diuresis represent promising new strategies.
• Further research is needed to solidify the role of agents like N-acetylcysteine and explore novel preventive methods.